Literature DB >> 24307783

Direct effects of hepatitis C virus on the lymphoid cells.

Yasuteru Kondo1, Tooru Shimosegawa.   

Abstract

It has been reported that the direct binding of hepatitis C virus (HCV) and/or the replication of HCV in the extrahepatic organs and, especially, lymphoid cells, might affect the pathogenesis of extrahepatic diseases with HCV infection. More than one decade ago, several reports described the existence of HCV-RNA in peripheral blood mononuclear cells. Moreover, many reports describing the existence of HCV in B lymphocytes and B cell lymphoma have been published. In addition to B lymphocytes, it was reported that HCV replication could be detected in T lymphocytes and T cell lines. Among the extrahepatic diseases with HCV infection, mixed cryoglobulinemia-related diseases and autoimmune-related diseases are important for understanding the immunopathogensis of HCV persistent infection. Moreover, HCV persistent infection can cause malignant lymphoma. The biological significance of lymphotropic HCV has not yet become clear. However, several candidates have been considered for a long time. One is that lymphotropic HCV is an HCV reservoir that might contribute to the recurrence of HCV infection and difficult-to-treat disease status. The other important issue is the carcinogenesis of the lymphoid cells and disturbances of the immune responses. Therefore, the extrahepatic diseases might be induced by direct interaction between HCV and lymphoid cells. In this article, we summarize various studies showing the direct effect of HCV on lymphoid cells and discuss the biological significance of lymphotropic HCV.

Entities:  

Keywords:  B cell; Hepatitis C virus; Immunology; Lymphotropism; T cell

Mesh:

Year:  2013        PMID: 24307783      PMCID: PMC3848137          DOI: 10.3748/wjg.v19.i44.7889

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  81 in total

Review 1.  Hepatitis C virus-related extra-hepatic disease--aetiopathogenesis and management.

Authors:  J Medina; L García-Buey; R Moreno-Otero
Journal:  Aliment Pharmacol Ther       Date:  2004-07-15       Impact factor: 8.171

2.  HCV-related immunocytoma and type II mixed cryoglobulinemia-associated autoantigens.

Authors:  Maria Paola Simula; Laura Caggiari; Annunziata Gloghini; Valli De Re
Journal:  Ann N Y Acad Sci       Date:  2007-09       Impact factor: 5.691

Review 3.  Autoimmunity and extrahepatic manifestations in hepatitis C virus infection.

Authors:  M P Manns; E G Rambusch
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

4.  Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.

Authors:  Shawn D Blackburn; Alison Crawford; Haina Shin; Antonio Polley; Gordon J Freeman; E John Wherry
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

5.  Hepatitis C virus in autoimmune liver disease in the UK: aetiological agent or artefact?

Authors:  B P Rowan; A Smith; D Gleeson; L P Hunt; T W Warnes
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

6.  Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction.

Authors:  L Muratori; D Gibellini; M Lenzi; M Cataleta; P Muratori; M C Morelli; F B Bianchi
Journal:  Blood       Date:  1996-10-01       Impact factor: 22.113

Review 7.  Hepatitis C infection and autoimmunity.

Authors:  A L Eddleston
Journal:  J Hepatol       Date:  1996       Impact factor: 25.083

8.  Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins.

Authors:  Keigo Machida; Kyoko Tsukiyama-Kohara; Satoshi Sekiguch; Eiji Seike; Shigenobu Tóne; Yukiko Hayashi; Yoshimi Tobita; Yuri Kasama; Masumi Shimizu; Hidemi Takahashi; Chyoji Taya; Hiromichi Yonekawa; Nobuyuki Tanaka; Michinori Kohara
Journal:  Gastroenterology       Date:  2009-04-09       Impact factor: 22.682

9.  Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection.

Authors:  Nadège Goutagny; Ahmed Fatmi; Victor De Ledinghen; François Penin; Patrice Couzigou; Geneviève Inchauspé; Christine Bain
Journal:  J Infect Dis       Date:  2003-05-29       Impact factor: 5.226

10.  Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines.

Authors:  Takayuki Abe; Yuuki Kaname; Itsuki Hamamoto; Yoshimi Tsuda; Xiaoyu Wen; Shuhei Taguwa; Kohji Moriishi; Osamu Takeuchi; Taro Kawai; Tatsuya Kanto; Norio Hayashi; Shizuo Akira; Yoshiharu Matsuura
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

View more
  9 in total

Review 1.  Hepatitis C and its impact on renal transplantation.

Authors:  Jose M Morales; Fabrizio Fabrizi
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

2.  Successful and Safe Long-Term Standard Antiviral Therapy in a Patient with "Explosive" Immune Response in Course of HCV-Related Liver Cirrhosis.

Authors:  Paolo Conca; Giovanni Cafaro; Amalia De Renzo; Antonio Coppola; Ernesto Cimino; Giovanni Tarantino
Journal:  Int J Mol Sci       Date:  2015-06-19       Impact factor: 5.923

3.  Patient-derived hepatitis C virus inhibits CD4⁺ but not CD8⁺ T lymphocyte proliferation in primary T cells.

Authors:  Sonya A MacParland; Annie Y Chen; Christopher P Corkum; Tram N Q Pham; Tomasz I Michalak
Journal:  Virol J       Date:  2015-06-19       Impact factor: 4.099

Review 4.  Hepatitis C and kidney disease: A narrative review.

Authors:  Rashad S Barsoum; Emad A William; Soha S Khalil
Journal:  J Adv Res       Date:  2016-07-26       Impact factor: 10.479

Review 5.  Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence.

Authors:  DeGaulle I Chigbu; Ronak Loonawat; Mohit Sehgal; Dip Patel; Pooja Jain
Journal:  Cells       Date:  2019-04-25       Impact factor: 6.600

6.  Single-Cell Chromatin Accessibility Data Combined with GWAS Improves Detection of Relevant Cell Types in 59 Complex Phenotypes.

Authors:  Akash Chandra Das; Aidin Foroutan; Brian Qian; Nader Hosseini Naghavi; Kayvan Shabani; Parisa Shooshtari
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

7.  Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4+ and CD8+ T Lymphocytes In Vitro.

Authors:  Georgia Skardasi; Annie Y Chen; Tomasz I Michalak
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

Review 8.  Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy.

Authors:  Arkadiusz Urbanowicz; Radosław Zagożdżon; Michał Ciszek
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2018-11-15       Impact factor: 4.291

9.  The reduction of miR146b-5p in monocytes and T cells could contribute to the immunopathogenesis of hepatitis C virus infection.

Authors:  Yasuteru Kondo; Takayuki Kogure; Masashi Ninomiya; Ryo Fukuda; Norikazu Monma; Kazuho Ikeo; Yasuhito Tanaka
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.